The effect of acute insulin infusion on the metabolism of calcium (Ca) and phosphate (P) was examined in 17 healthy subjects. They were hospitalized and kept on a constant diet for 5 days, and an euglycemic hyperinsulinemic glucose clamp was applied. Synthetic human insulin was infused at the rate of 40 mU/m2/min for 2 hr, and glucose was also infused to maintain basal glucose levels of each subject. The control study was performed in 8 of the 17 subjects, into whom 10% xylitol was infused for 2 hr at the rate of 100 ml/hr. The plasma insulin concentrations were 7.94±0.35 and 62.3± 14.3 mU/liter before and after the glucose clamp technique, but serum free Ca ion was increased significantly (p < 0.05), and serum P and serum parathyroid hormone (PTH) were decreased significantly (p <0.001). Creatinine clearance did not change during the glucose clamp technique. Urinary excretion of Ca (UCaV) was significantly higher after the glucose clamp than the control study. Fractional excretion of Ca (FECa) was increased significantly (p <0.05), and urinary excretion of P (UPV) and fractional excretion of P (FEP) were decreased significantly (p <0.05) under the hyperinsulinemic condition. The results suggested that, under the conditions of euglycemic hyperinsulinemia by glucose clamp technique, insulin increased the serum free Ca ion, and as a result, PTH was suppressed. Decreased PTH might induce calciuresis and enhance tubular P reabsorption under hyperinsulinemia. Insulin increased serum free Ca ion might relate to the vasodilating action of insulin by its decrease of intracellular free Ca ion in vascular smooth muscle.
Epidemiological and clinical evidence has indicated a close association between insulin resistance and essential hypertension (Christlieb and Krolewsky 1985; Modan et al. 1985; Landsberg 1986 ). The pancreas raises the level of circulating insulin in response to insulin resistance, and this higher level is speculated to bring about hypertension through the resulting vasoconstriction (DeFronzo and Ferrannini 1991). However, it has been reported that acute administration of insulin has a vasodilating effect which may be due to the inhibition of the response to vasoconstrictive action of noradrenaline and angiotensin II (Liang et al. 1982) . If an acute effect of insulin reveals the decrease of intracellular Ca ion level in vascular smooth muscle, it may also contribute to its vasodilating action.
It has been indicated that insulin may affect the transmenbranous electrolyte exchange systems of not only sodium (Na) but also potassium (K), magnesium (Mg) and calcium (Ca) through Na+-K+ ATPase, the Na+-H+ antiporter, the Na+-Ca2+ antiporter and so on (Mullins 1976 Fidelman et al. 1982 ). Pershadsingh and McDonald (1979) demonstrated that the intracellular Ca ion in adipocyte was increased rapidly by insulin through the inhibition of Cat+_Mg2+ ATPase. On the other hand, insulin stimulates the efflux of Ca ion from isolated intact rat soleus muscle (Clausen and Martin 1977) . Thus, it is still controversial whether the acute effect of insulin decreases intracellular Ca ion or not.
Regarding renal Ca handling, several reports have demonstrated that insulin regulated Ca and phosphate (P) metabolism in the kidney (DeFronzo et al. 1975 (DeFronzo et al. , 1976 Guntupalli et al. 1989) . DeFronzo et al. (1975) suggested that insulin might act on renal distal tubules and enhance Ca excretion in a human clearance study. On the other hand, insulin is believed to promote cellular P uptake and enhance tubular P reabsorption at proximal and distal tubules in dog (DeFronzo et al. 1976 ). Thus, insulin might be related to the release of PTH which is the regulating hormone of Ca and P. But there have been few reports regarding the relation between PTH levels or serum free Ca ion and hyperinsulinemia.
In the present study, we investigated the effect of insulin on the metabolism of Ca, P and PTH.
SUBJECTS AND METHODS
Seventeen non-obese male subjects (age 20.9+0.3 years old, mean±S.E.) were employed in this study. They were all normotensive volunteers without any medication. Informed consent was given by all the subjects before the study. Their body mass index was 21.9 + 0.5 kg/m2 (mean ± s.E. ). They were hospitalized and kept on a constant diet (Na: 120 mEq/day, K: 75 mEq/day, Ca: 600 mg/ day) for 5 days. Compliance with the diet was confirmed by measurement of the 24-hr urine electrolytes in the excretions on the fourth day. The euglycemic hyperinsulinemic glucose clamp technique was performed with a model artificial endocrine pancreas (Nikkiso Corp., Tokyo) on the 17 subjects on the fifth day. One hundred milliliters of tap water was ingested at 7 : 00 am, and after complete urination, 200 ml of tap water was ingested at 8 : 00 am. The subjects were kept in supine position and the first urine was collected between 9 : 30 am to 10:00 am. Then a vein was cannulated in a lower arm for blood glucose monitoring, and a contro-lateral arm vein was cannulated for blood sampling and the infusions of insulin and glucose. Insulin (Act rapid Human, Novo Industries, Copenhagen, Denmark) was dissolved at a concentration of 40 U/ml in physiological saline and infused at a rate of 120 mU/m2/min for the first 15 min from the start of infusion, then at 40 mU/m2/min for the following period until 120 min. Twenty percent glucose solution was infused to maintain the basal plasma glucose level of each subject. Blood samples were taken two times. The first was done 30 min after cannulation, then hyperinsulinemic euglycemic glucose clamp technique was begun for 2 hr. The second was taken immediately following the end of the glucose clamp. Urine samples were collected before and after the glucose clamp technique. The control study was performed in 8 of the same 17 subjects (age 20.8± 0.3 years, BMI 23.2 ±0.4 kg/m2, mean ± s.E.) on the fourth day. They were given water and asked to urinate completely in the same procedure as in the glucose clamp study, and 10% xylitol solution was infused i.v. for 2 hr at a rate of 100 ml/hr. Blood and urine samples were taken before and after the procedure in the same way as in the glucose clamp study.
In the two studies, serum phosphate (P), serum calcium (Ca), serum free Ca ion, serum creatinine, plasma glucose, plasma parathyroid hormone concentration (PTH), and plasma insulin concentration were measured, and urinary excretion of P (UPV), fractional excretion of P (FEP), urinary excretion of Ca (UCaV), fractional excretion of Ca (FECa), and creatinine clearance were calculated. Plasma insulin and PTH were measured by radioimmunoassays of insulin RIA beads (Dainabot, Tokyo) and parathyroid hormone RIA kit Yamasa (Yamasa Corp., Tokyo).
Statistical analysis
All data are expressed as mean +s.E. Student's t-test was used to assess differences between before and after the glucose clamp and in the control studies.
RESULTS
Neither the control nor the glucose clamp group showed any significant changes in 24-hr UNaV (104.1 ± 8.2 and 96.4 ± 6.6 mEq/day, respectively) or 24-hr UCaV (91.4+ 12.1 and 93.0+ 11.3 mg/day, respectively) on the fourth day. The plasma insulin concentrations were 7.94 + 0.35 and 62.3 + 14.3 mU/liter before and after the insulin infusion by glucose clamp, respectively (Table 1 ). In the control group, plasma glucose, plasma insulin, serum Ca, free Ca ion, P and PTH did not change significantly. During the glucose clamp technique, plasma glucose levels were kept at the basal levels. Fig. 1 shows the plasma glucose and insulin levels, and the insulin infusion rate during the glucose clamp in a normotensive subject. Serum Ca did not change significantly, but serum free Ca ion increased (p <0.05) compared with the basal levels. Serum P and serum PTH were decreased considerably (p <0.001) in the hyperinsulinemic condition from the basal levels. Both values were significantly lower than in the control group. Creatinine clearance did not change following the glucose clamp study (Table 2 ). In the control study, a significant decrease was observed in UCaV and FECa, and FEP increased significantly after xylitol infusion. After the glucose clamp study, UCaY did not change significantly in the glucose clamp study. However, UCaV was significantly higher in glucose clamp study than in the control. FECa was 
DISCUSSION
This study investigated the effect of acute level of insulin on the metabolism of Ca and P in nonobese normotensive subjects. In the control study, UCaV and FECa were decreased significantly (p <0.05), and FEP was increased significantly (p <0.05) ( Table 2) , although there were no changes in blood parameters (Table 1) . It was reported that excretion of Ca is higher in the early morning and lower in the evening and P excretion followed a pattern almost 180° out of phase with Ca excretion (Min et al. 1966) , suggesting a circadian rhythm for UCaV and UPV. Therefore, the increases of UCaV, FECa, UPV and FEP observed in the control study may be part of some circadian rhythm.
In our study, serum free Ca ion was slightly but significantly increased under the physiological hyperinsulinemic condition. The increase of serum free Ca ion levels cannot be explained by renal Ca ion excretion, because calciuresis is associated with this. The Ca release from bone tissue does not seem to be concerned to its mechanism, because plasma PTH levels were significantly suppressed during the clamp. However, the presence of insulin receptor in osteoblastic cells (Levy et al. 1986 ) and lower plasma Ca levels in diabetic rats (Ishida et al. 1988 ) suggest the insulin action on bone tissue. Thus, the direct effects of insulin on bone tissue may contribute to the increased plasma ionized Ca levels caused by hyperinsulinemic.
Regarding to the role of 1, 25(OH)2 vitamine D3, it has been reported that the decrease of 1, 25(OH)2 vitamine D3 and the depressed intestinal calcium absorption in diabetic rats are restored by insulin supplementation (Spencer et al. 1980 ). However, Ishida et al. (1985) reported that 1, 25(OH)2 In an investigation of the variation of PTH level under hyperinsulinemia, Rumenapf et al. (1990) found that serum PTH level did not change under euglycemic hyperinsulinemic condition. Although the subjects did not take a constant diet before experiment in their study, UCaV was three times higher than found in our study. If the subjects in their study had taken a large amount of Ca, serum PTH level might have been suppressed at the basal condition; this could have masked the variation of PTH in hyperinsulinemia. This would explain the discrepancy with our findings.
It has been reported that insulin has a caluciuretic action (Lindeman et al. 1967 ; Lennon and Piering 1970; Boner et al. 1973 ; Lennon et al. 1974 ). DeFronzo et al. (1975) suggested that insulin acts on the renal distal tubules and inhibits Ca reabsorption in a human clearance study. In the present study, the glucose clamp raised UCaV and FECa significantly over those in the control study. Thus, increased urinary Ca excretion in our study might be explained by direct insulin action on Ca transport, and this could be augmented by decreased PTH.
In this study, serum P, UPV and FEP decreased during the hyperinsulinemic state. It is well known that insulin may promote cellular P uptake, which may be mediated partly by /3-adrenergic receptors (Massara and Camanni 1970) . Moreover, insulin augmented tubular phosphate reabsorption in human clearance study (DeFronzo et al. 1975) , the mechanism of which is speculated to be the direct action of insulin, according to observation of an isolated perfused dog kidney (Nizet et al. 1971 ). DeFronzo et al. (1976) suggested that insulin enhanced tubular P reabsorption at proximal and distal tubules with recollection micropuncture technique in dog. Euglycemic hyperinsulinemia completely reversed the decline of tubular reabsorption of P induced by PTH infusion in parathyroidectomized rats (Guntupalli et al. 1989 ). These studies indicate that insulin has its own action to enhance tubular P reabsorption independent of PTH.
These results suggest that hyperinsulinemia increases serum free Ca ion and consequently, suppresses serum PTH. This action may relate to the vasodilating action of insulin by decreasing intracellular free Ca ion in vascular smooth muscle. 
